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T H E USE O F FUSION PROTEINS TO S T U D Y 
HLA-B27-SPECIFIC A L L O R E C O G N I T I O N 
G E R H I L D W I L D N E R * ! , ELISABETH H . WEISS, HANNELORE S Z Ö T S J , G E R T R I E T H M Ü L L E R and 
DOLORES J . S C H E N D E L 
Institute for Immunology, Goethestr. 31, D-8000 München 2, F.R.G. 
{First received 1 April 1988; accepted in revised form 22 June 1988) 
Abstract—Potential antigenic regions of the various external domains of the HLA-B27 antigen were 
expressed as fusion proteins in bacterial hosts and analyzed for their ability to induce humoral and cellular 
responses. Monoclonal antibodies directed against the proteins recognized monomorphic determinants of 
denatured HLA-antigens, but not B27-antigens expressed by intact lymphocytes. T-cell proliferation and 
IL-2 secretion were induced with a fusion protein representing regions of the first and second domains 
around amino acid residue 114. None of the fusion proteins stimulated cytotoxic T-lymphocytes (CTL) 
in an HLA-specific manner, although several included those amino acid sequences thought to be important 
for C TL recognition. 
I N T R O D U C T I O N 
While B-lymphocytes directly bind native antigens 
with their immunoglobulin receptors, T-cells only 
recognize processed antigenic peptides which are 
presented to their receptors in association with self-
M H C molecules (Zinkernagel and Doherty, 1979). 
The M H C molecules present peptides to T-cells with 
a distinct class related bias: class I molecules predom-
inantly activate cytotoxic T-lymphocytes (CTL); 
whereas class I I molecules primarily stimulate helper 
T-cells. Recent studies have emphasized that antigen 
presenting cells need to intracellular^ process intact 
antigens into peptides which are bound by restricted 
sites of M H C molecules, forming a complex 
( se l f+X) (Allen, 1987). These complexes are trans-
ported to the cell surface where they are accessible to 
T-cell receptor recognition. Since a very high per-
centage of T-cells apparently have receptors specific 
for allogeneic M H C molecules (Lindahl and Wilson, 
1977) the question arises whether alloantigens, as 
typical integral membrane proteins, are also intra-
cellularly processed and seen as peptides in associ-
ation with self-MHC molecules (Kourilsky and 
Claverie, 1986, Bjorkman et ai, 1987; Clayberger 
et ai, 1987) or whether conformation allows the 
display of an allogeneic stretch of residues sufficient 
to be recognized by T-cells as a s e l f + X complex. 
To investigate this question we studied responses 
by T-cells and humoral antibodies to the well known 
human alloantigen HLA-B27. For this purpose 
cDNA fragments of the B27 gene, encoding various 
•Present address: Max-Planck-Institute for Biochemistry, 
A m Klopferspitz 18a, D-8033 Martinsried, F.R.G. 
fAuthor to whom correspondence should be addressed. 
JPresent address: Institute for Experim. Hematology, 
Landwehrstr. 61, D-8000 München 2, F.R.G. 
segments of the first and second domains, were 
cloned into expression vectors and recovered as fu-
sion proteins. The resultant fusion proteins included 
stretches of residues which, following processing, 
should provide important allogeneic determinants. 
They should also display limited conformational 
determinants, although these would be clearly dis-
tinct from those of the native molecules. These fusion 
proteins were used to study induction of monoclonal 
antibodies in mice in vivo and induction of human 
helper and cytotoxic T-cell subsets in vitro. The 
response of T-helper cells was measured by IL-2 
secretion and C T L reactivity by lysis of allogeneic 
target cells. T-helper cells could be stimulated to 
secrete IL-2 with a fusion protein containing the 
combined first and second domains, while C T L were 
non-specifically activated by some fraction of the 
bacterial lysate. Monoclonal antibodies induced 
against the various fusion proteins precipitated H L A -
class I antigens from cellular lysates, as shown in 
Western blot and isoelectric focussing, but were not 
specific for HLA-B27. 
M A T E R I A L S AND M E T H O D S 
Cloning ofHLA - B 2 1 cDNA fragments into expression 
vectors 
B27 c D N A fragments (Szöts et ai, 1986) (Fig. 1) 
were cloned into the expression vectors pExl (Stanley 
and Luzio, 1984) and pExlO (Seedorf et ai, 1987) 
providing transcripts fused with ß galactosidase in 
the case of pExl and MS2 polymerase in the case of 
pExlO. Translation of fusion protein D3 will termi-
nate at the end of a 3 due to a stop codon: therefore 
D3 wil l only express a peptide corresponding to 
amino acid positions 180-274. The complete first 
domain could not be obtained since the c D N A clone 
used for these experiments started at amino acid 27 
33 
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and the restriction site at position 37 was chosen to 
eliminate the poly-T-tail resulting from the transcrip-
tion of m R N A to cDNA. Correct fit of each 
B27-cDNA fragment into the reading frame of the 
expression vector was controlled by D N A sequencing 
with the method of Sanger et ai (1977). 
Expression and purification of fusion proteins 
Expression of fusion proteins was induced with a 
heat shock of 42°C [to inactivate the thermosensitive 
repressor of the E. coli strains pop (for pExl ) and 537 
(for pExlO)). Overnight cultures, grown at 30 C, were 
diluted four-fold with fresh medium which was pre-
warmed (45°C) to obtain a fast temperature shift. 
After shaking for 1-4 hr (42°C) the cultures were 
sedimented, the pellet resuspended in 1/10 vol glucose 
buffer (50 m M glucose, 10 mM EDTA, 25 m M 
Tris-HCl , pH 8.0) and sonicated for 2 min. After 
centrifugation for 20 min at 4000 # the pellet was 
resuspended in 1 M urea, sonicated and centrifuged 
again for 20 min at 4000 g. The resulting pellet was 
again resuspended in 7 M urea and sonicated for 
2 min. Following centrifugation the supernatant was 
dialyzed against H 2 0 for 2-3 days, lyophilized and 
the protein weight determined. Fusion proteins were 
resuspended in phosphate buffered saline (PBS) and 
sonicated for 5 min to obtain a fine suspension. 
Due to their insolubility, the fusion proteins were 
not easily purified by gel chromatography without 
prior treatment with strong detergents. For use in 
cellular assays they needed to be detergent-free, thus 
urea was used and subsequently removed by dialysis. 
The enriched fusion proteins, however, were con-
taminated by a fraction of urea soluble bacterial 
proteins. 
Al l fusion proteins could be produced in high 
amounts compared to total bacterial protein, except 
for the unfused MS2 polymerase. The failure to 
induce high amounts of MS2 polymerase remains 
unexplained, although it may have been due to 
degradation by proteases. 
Generation of monoclonal antibodies against fusion 
proteins 
Six-week-old F l mice (C57B1/6 x BALB/c) were 
immunized twice i.p. at weekly intervals with a 
mixture of 50pg each of the fusion proteins 
MS2-D1/2, - D l , -D2 and -D3, mixed with 109 B. 
pertussis. After 7 days they were boosted i.v. with the 
same amount of antigen alone and 3 days later the 
spleen cells were fused with the myeloma line X63 
Ag8.653 according to the protocol of Hämmerling 
(1977). Supernatants were tested for binding to MS 
2-fusion proteins as follows: round-bottom PVC-
plates (Falcon, Becton Dickinson, Oxnard, CA) were 
coated (4°C, overnight) with 50-100//l of MS 
2-fusion protein, dissolved in 7 M urea and then 
diluted to a concn of 5-10 //g/ml PBS. After blocking 
with PBS containing 3% fetal calf serum (FCS) 
(37°C, 2 hr) and incubation with culture supernatants 
(4°C, overnight) a peroxidase-coupled rabbit anti-
mouse-Ig antibody (P 161, Dianova, Hamburg) was 
added for 1-2 hr (37°C); O-phenylendiamine (Sigma, 
St Louis, MO) (1 mg/ml) dissolved in 0.1 M citrate 
buffer, pH 8, containing 0.01% H 2 0 2 was used as a 
substrate for the peroxidase. Peroxidase activity was 
determined according to the substrate absorption at 
450 nm. 
Precipitation of HLA-antigens from cell lysates 
Monoclonal antibodies were covalently crosslinked 
to rabbit anti-mouse-Ig-coupled Protein A-Sepharose 
according to the protocol of Gersten and March-
alonis (1978). Cellular lysates were prepared as de-
scribed by Vasilov et ai (1983). HLA-antigens from 
cell lysates were incubated with the antibody-coupled 
Sepharose for at least 2 hr at 4°C. Before eluting the 
antigens with 50 m M desoxycholate (pH11.2) the 
Sepharose was washed 3 x with NET (150 m M NaCl, 
10 m M Tris-HCl pH 7.6, 1 m M EDTA, 0.5% NP 
40). The eluate was then titrated to pH 7.4 with 1/10 
volume of 0.5 M K H 2 P 0 4 , mixed with SDS-sample 
buffer and applied on a 12.5% SDS-PAGE. 
The Western blots were made according to Towbin 
et ai. (1979). The blot was developed with the H L A -
heavy chain specific monoclonal antibody H C 10 
(Stam et ai, 1986; Neefjes, 1986), anti-mouse-
immunoglobulin-coupled horse radish peroxidase 
(Dianova, Hamburg) and using sodium dianisidine 
and nitroprusside as substrate. 
Isoelectric focussing 
1.5 x 106cells were labelled with 25/ iCi 
3 5S-methionine. HLA-antigens were precipitated as 
described above but including a 4 hr preabsorption 
with rabbit anti-mouse-Ig-Protein A-Sepharose. 
After immunoprecipitation with the specific anti-
bodies, the Sepharose complex was washed twice with 
each of the following buffers (A, B, C): A: 0.05 M 
Tris-HCl, pH8.2, 1 m M EDTA, 0.5 M NaCl, 
0.5% taurocholate; B: 0.05 M Tris-HCl, p H 8.2, 
0 .15M NaCl, 0.5% taurocholate, 0 .1% SDS; C: 
0.05 M Tr is -HCl , pH 8.2, 0.15 M NaCl, 0.5% tauro-
cholate. The samples were treated with neuramini-
dase (Type V I I I , Sigma, St Louis, MO) in reaction 
buffer (50 m M NaAc, pH 5.0, 1 m M CaCl 2 ) for 4 hr 
at 37°C. The antigen was eluted from the Sepharose 
by adding IEF-sample buffer and applied on an 
IEF-gel as described (Neefjes, 1986). 
Preparation of antigen presenting cells (APC) 
A l l cell cultures were maintained in RPMI 1640 in 
a 5% C0 2-humidified air atmosphere. Fresh periph-
eral blood of HLA-typed donors was defibrinated 
using sterile glass beads, serum was collected and the 
fibrin clots were incubated (37°C, overnight) in 
R P M I medium containing 15% autologous serum. 
Monocytes that had migrated from the fibrin clots 
were isolated by ficoll gradient centrifugation 
(Schendel and Wank, 1981). The interface cells were 
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Fig. 1. Restriction map of B27-cDNA showing the cDNA-fragments used for the construction of the 
fusion proteins D l / 2 , D l , D2 and D3. 
washed three times with R P M I prior to incubation 
with fusion proteins. Monocytes or Epstein-Barr-
Virus-transformed B-lymphoblastoid cell lines (LCL) 
were incubated with 500-1000 jug of fusion protein 
per 106 cells in RPMI containing 10% autologous 
serum (for monocytes) or 10% FCS (for LCL) at 
37CC for at least 6 hr or overnight. Before being used 
as antigen presenting cells the remaining fusion pro-
tein was removed by a ficoll gradient. L C L were 
irradiated with 5000 rad, monocytes with 2000 rad. 
In vitro stimulation of IL 2-secreting cells 
1 x 106 peripheral blood lymphocytes (PBL) were 
incubated with 2 x 105 allogeneic stimulator cells or 
fusion protein pulsed APC in 1 ml RPMI containing 
10% pooled human serum. During primary stimu-
lation, supernatants were collected after 18, 24, 48, 72 
and 96 hr. For restimulation cells were harvested 
after 10 days, washed and incubated at a concn of 
10 6/ml with the same number of irradiated PBL as 
stimulator cells. Supernatants were collected after 5, 
14, 18, 24 and 36 hr. IL-2 content of the supernatants 
were measured by 3H-thymidine incorporation of an 
IL-2 dependent cell line as described previously 
(Schendel and Wank, 1981). 2 x 104 IL-2 dependent 
cells were incubated in 50 p] R P M I 1640/10% pooled 
human serum plus 50 ^1 of test supernatant in round 
bottom microtiter plates. After 3 days incubation 
2 ji Ci 3H-thymidine were added per well and cultures 
were incubated for another 8 hr. Cells were 
then harvested and incorporated radioactivity was 
measured. 
In vitro generation of CTL 
5 x 106 PBL cells were incubated in an upright 
50 ml culture flask with 5 x 106 allogeneic PBL 
(2000 rad) or 1 x 106 fusion protein-pulsed auto-
logous APC (LCL or monocytes) in 7 ml R P M I 
1640/10% pooled human serum. After 6 days cells 
were harvested and cytotoxicity was tested in a 4 hr 
chromium release assay on 5 1Cr-labelled L C L or 
3-4 d phytohemagglutinin (PHA) stimulated blasts. 
10 3/100/il 5 lCr-labelled target cells were incubated 
with 100/d effector cells of varying dilutions in 
RPMI/10% FCS for 4h r at 37°C. Spontaneous 
chromium release was determined by incubating la-
belled target cells in culture medium only and total 
release by directly measuring the labelled cells. 
Specific lysis (%) was calculated from the average 
of triplicates according to the following formula 
(Schendel et al., 1979): (experiment 5 1 Cr release-
spontaneous release): (max. 5 l Cr release-spontaneous 
release) x 100. 
R E S U L T S 
Generation of fusion proteins 
Our goal to obtain single, complete domains of the 
HLA-B27 chain was partially limited by the lack of 
appropriate restriction sites for cloning into the vec-
tor pEx l . As the restriction map of B27-cDNA 
demonstrates (Fig. 1), the second and the third 
domains could be easily separated, whereas no suit-
able restriction site was available between the first 
and second domains. Thus fusion protein D l / 2 con-
sisted of about half of the first domain and the 
complete second domain, whereas D l is composed of 
half of the first and 1 /3 of the second domain and D2 
contained 2/3 of the second domain. The third do-
main (D3) was fully expressed and since the c D N A 
clone had a stop codon at the end of the third 
extracellular domain, the expression of the cyto-
plasmic and intracellular regions was avoided. The 
genes for MS2-polymerase or ß galactosidase were 
fused to the 5'-end of the cDNA-segments. 
Antibody responses to fusion proteins 
The monoclonal antibodies generated against the 
various fusion proteins that were selected for further 
characterization are listed in Table 1. Only those were 
selected which showed differential binding to the 
various fusion proteins and did not react with the 
MS2-polymerase control fraction, with the exception 
of MS39, which reacted with all fusion proteins and 
MS2-polymerase. Antibody MS52 preferentially 
bound to fusion protein D3, whereas the others 
recognized D l / 2 , D l and D3. One antibody recog-
nized only D l or D l / 2 , namely HC 10 (Stam et ai, 
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Table 1. Binding of the monoclonal antibodies to the MS2-polymerase fusion proteins 
Dl /2 D l D2 D3 MS2 
H C 10 + + + + * + + + + - - -
W6/32 - - -
MS 6 + + + + + + + + _ + + + + -
MS 10 + + + + + + - + + + -
MS 17 + + + + + + - + + + -
MS 32 + + + + + + + + - + + + + -
MS 39 + + + + 4- + + + + + + + + + + + + + + 
MS 52 + + + + - + + + + -
450 nm. + + + -f E 4 M ) > 2.0; + + + E 4 5 ( , > 1.5: + + E 4 5 ( L > 1.0; E 4 5 ( L 0.0-0.3. 
1986), a reagent that was generated against papain 
digested, sodium dodecyl sulfate denatured heavy 
chains of H L A - B . The binding of MS6, 10, 17 and 32 
to both D l and D3 suggested they share antigenic 
epitopes, although they have no similarities in amino 
acid sequence. 
The monoclonal antibodies, W6/32 and HC 10 
were used to precipitate HLA-antigen from cellular 
lysates. Isolates of the mouse mastocytoma line P815 
(Van Pel et ai, 1985) transfected with HLA-B27 
(Kuon et al., personal communication) as well as the 
untransfected control were tested in a Western blot 
(Fig. 2). The anti-fusion protein antibodies did not 
recognize SDS denatured antigens (data not shown), 
so they could not be used for development of the 
blots. When, however, the blots were developed with 
the HLA-heavy chain specific antibody HC 10 (Stam 
et ai, 1986), bands corresponding to class I molecules 
were found in all precipitates of the transfected line, 
but not with the non-transfected cell. The same 
pattern appeared after precipitation of HLA-antigens 
from the L C L LG2 (HLA-A2 , -B27, -Cwl) 
(unpublished observations). 
Further analysis of the antigens precipitated from 
the HLA-homozygous L C L LG2 (A2, B27, C w l ) was 
done by isoelectric focussing. The autoradiography 
(Fig. 3) shows the pattern of bands expected for 
H L A - A 2 , B27 and Cwl (Neefjes et al., 1986; Gussow 
et ai, 1987). Only in the case of Cwl the anti-fusion 
protein-antibodies differed in pattern and intensity 
from HC10. 
These data suggest that the antibodies recognize an 
HLA-class I-specific, monomorphic determinant on 
slightly denatured HLA-antigens. Since the anti-
fusion protein monoclonal antibodies do not directly 
bind to cells and cannot recognize fully denatured 
class I molecules, but can precipitate class I mole-
cules, they seem to recognize a slightly denatured 
form of class I antigens. 
Cellular responses to fusion proteins 
Helper-like responses were analyzed by measuring 
the induction of IL-2 secretion from PBL stimulated 
with fusion protein presented by autologous mono-
cytes. Two fusion proteins were able to stimulate 
T-cells to secrete IL-2 (Table 2a). Some determinants 
t ^ 
4 | 4 3 k D 
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Fig. 2. Western blot. Isolation of B27 antigen from the mouse mastocytoma lines P815 (P) and P815/B27R 3 
(T) (P815 transfected with the B27-gene) with the monoclonal antibodies MS6, MS10, MS17, MS32, 
MS39, MS52 and W6/32. The blot was developed with the monoclonal antibody HC 10. The lysates were 
prepared from 5 x 107 B27R ?-cells and 4 x 107 P815-cells. 
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determinants present in D l / 2 , however, may be more 
important, since IL-2 induction with this fusion 
protein approached levels induced by PHA stimu-
lation of PBL. 
To determine i f the initial stimulation of the PBL 
with fusion proteins led to a specific priming for 
alloantigen (i.e. HLA-B27 specific), the same cultures 
were restimulated on day 10 with irradiated B27 + and 
B27~ PBL (Table 2b). Only those cells that were 
initially sensitized with fusion protein D l / 2 produced 
high amounts of IL-2 in the secondary cultures. 
There may have been some preferential activation of 
T-cells specific for B27-associated allodeterminants, 
since the B27 + PBL restimulated higher IL-2 secre-
tion than the B27 PBL. The rapid decrease in IL-2 
levels between 5 and 14 hr may occur because the 
primed responder T-cells themselves utilize IL-2. 
Induction of CTL 
The ability of the fusion protein D l / 2 to 
induce C T L was tested by stimulating PBL of two 
different B27-negative donors with fusion protein 
/i-galactosidase-Dl/2 or /?-galactosidase alone, 
presented either by autologous monocytes or B27~ 
allogeneic LCL. Cytotoxicity was tested on B27 + and 
B27~ target L C L (Fig. 4). Effector cells from both 
donors showed much greater cytotoxicity of the B27 + 
target cells than of the B27~ targets, however this 
difference was also found with cells stimulated with 
/?-galactosidase alone. Thus, there was no evidence 
for induction of B27-specific C T L by this fusion 
protein. 
Table 2a. IL-2 secretion of T-cells activated by fusion proteins* 
18 hr 24 hr 48 hr 
Dl /2 51,315 ± 3317f 56,030 ± 4051 11.725 ± 4 1 8 6 
D l 396 ± 99 1056 ± 8 2 3 773 ± 265 
D2 3799 ± 6 1 1 4012 ± 6 2 4 7691 ± 1093 
D3 766 ± 279 695 ± 89 431 + 15 
MS2-Pol 708 ± 157 584 ± 72 569 + 189 
Controls: 5 units recombin. IL-2/ml: 71,356 ± 4 4 9 1 ; 2,5 units recombin. IL-2/ml: 
30,271 ± 1647; 1% PHA: 461 ± 137; RPMI-medium: 483 ± 169. 
*Donor cells W G ( H L A - A 2 , A3, B13, B44, Cw6) were stimulated with fusion protein 
pulsed autologous macrophages. 1 x 10 6 PBL were cocultivated with 5 x 105 
fusion protein presenting macrophages in 2 ml RPMI-medium with 10% human 
serum. Culture supernatant was harvested after 18, 24 and 48 hours and tested 
for its content of IL-2 by 3H-thymidine incorporation of an IL-2 dependent cell 
line. 
tData represent averages ( ± I S.D.) of triplicate values. 
Table 2b. Restimulation of fusion protein-primed cells with B27 + and B27 donor cells* 
D l /2 D l D2 D3 MS2-Pol 
B27 + P B L 5hr 10,825 ± 1370t 422 ± 7 1 580 + 215 708 ± 2 1 2 333 ± 103 
14 hr 983 ± 352 1013 ± 1 5 0 824 + 467 1319 ± 350 1865 + 822 
B27 P B L 5hr 6488 ± 1093 580 ± 307 420 ± 117 480 + 55 480 ± 208 
14 hr 496 ± 72 473 ± 5 1 643 ± 334 628 + 208 628 ± 208 
Controls: 5 units rec. IL-2/ml: 71,356 ± 4 4 9 1 ; 2,5 units rec. IL-2/ml: 30,271 ± 1647; 1% PHA: 461 ± 137; 
RPMI-medium: 483 ± 169. 
*B27 + P B L E L : H L A - A 2 , B8, B27, Cw2, Cw7, DR3, D R w l 3 , D Q w l . DQw2. B27 P B L ST: H L A - A l , A26, B8, 
B14, Cw7, Cw8, DR3. DR7. 
Ten days after primary stimulation with fusion protein presenting macrophages (see Table 2), P B L W G ( H L A - A 2 , 
A3, B13, B44, Cw6) were restimulated with the same number of B 2 7 + ( E L ) and B27^ (ST) P B L (106 cells/ml). 
After 5, 14, 18, 24 and 36 hr culture supernatant was collected and the content of IL-2 was determined. The table 
shows only the data from 5 and 14 hr supernatants, since at later times no significant responses were detected. 
tData represent average ( ± I S.D.) of triplicate values. 
6 10 17 32 39 52 HC 
11 *' * * * i 
Fig. 3. Isoelectric focussing. Precipitation of HLA-class 
I-antigens from B-LCL LG2 with the monoclonal anti-
bodies MS6, MS10, MS17, MS32, MS39, MS52 and HC10. 
important for induction of IL-2-secretion may be 
located near residue 114 in the second domain ( D l 
and D2 are dissected at this site). Conformational 
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Fig. 4. Cytotoxicity of fusion protein prestimulated donor 
cells. Effector cells E l ( H L A - A 2 , B18, B60, Cw3, Cw8) and 
E2 ( H L A - A 2 , A3, B35, B37, Cw4) were stimulated with 
autologous macrophages pulsed with fusion proteins 
Dl/2-/?-galactosidase and ß -galactosidase alone and with 
L C L M L ( H L A - A 2 , A3, B7, B27, Cw2). Target cells were 
L C L T l ( H L A - A 2 , A3, B27, B35) and L C L T2 ( H L A - A 2 , 
A3, B35, B37, Cw4) as B27-negative control. A Effectors E l 
tested on targets T l (B27 + ) ; A Effectors E l tested on targets 
T2 (B27-); • Effectors E2 tested on targets T l (B27 + ) ; 0 
Effectors E2 tested on targets T2 (B27~). 
Inhibition of CTL 
The fusion proteins were also tested for their 
abilities to inhibit target cell lysis. Effector cells were 
stimulated with B27 + PBL and propagated for 21 
days in the presence of IL-2. The C T L line was then 
analyzed for lysis of a target cell ( H L A - A 2 , B27, 
C w l ) that differed only by B27 from the effector cells 
(HLA-A2 , B17, B51, C w l , Cw6). Varying amounts of 
fusion proteins were added to this C M L combination 
(Fig. 5). Inhibition of up to 50% was found using 
100 jug/well of MS2-fusion proteins. Again, all fusion 
proteins, including the control fraction of MS2 alone, 
inhibited lysis. Therefore, as with the induction of 
effector cells, it seemed that some bacterial protein 
non-specifically influenced the cytotoxic T-cell 
response. 
D I S C U S S I O N 
Elucidation of the nature of the epitopes on allo-
antigens that elicit various immune responses has 
been studied thus far in two principal ways. Exon 
shuffling between different alleles was used to create 
new hybrid molecules, whose antigenicity for cyto-
toxic T-cells could be investigated (Ozato et ai, 1983; 
Arnold et ai, 1984, 1985). These experiments re-
vealed that residues in the first and second domains, 
as well as conformation dependent epitopes are 
recognized by CTL. Similar results were obtained by 
comparing natural recombinant H L A - A genes in 
man (Clayberger et ai, 1985). Alternatively, C T L 
have been identified that can distinguish among 
variant class I molecules and sequence comparisons 
enabled identification of the antigenic regions im-
portant for CTL recognition. This approach revealed 
that residues 77-80 and 152-156 seem to be critical 
for alloantigen recognition by both human (Lopez de 
Castro et ai, 1985; Parham et ai, 1987) and mouse 
(Nathenson et ai, 1986) CTL. Peptides covering 
these amino acid stretches could also be recognized 
by cytotoxic T-cells (Walker et ai, 1985; Maryanski 
et ai, 1986; Parham et ai, 1987). While the results of 
the first approach point to the necessity of con-
formation, the restricted amino acid differences 
found in the second case imply an important role for 
short peptide sequences although how recognition of 
these stretches is dependent on conformation remains 
undefined. Fusion proteins offer a third way to study 
T-cell recognition of discrete regions of an H L A 
molecule. Since it is difficult to determine a priori the 
peptide regions antigenic for B- or T-cells, fusion 
proteins would seem to provide an ideal tool since 
sequences larger than peptides, nevertheless much 
more restricted in size than complete H L A molecules, 
can be easily generated. These longer sequences may 
also attain partial folding necessary for immune 
recognition. 
As the binding studies to fusion proteins show, the 
monoclonal antibodies do not recognize deter-
minants that are specific for B27. Except for antibody 
DI /2 Dl D2 03 MS2-P0L 
XT 
' - J 
1 1 1 1 I 1 I 1 
/ 
i I I I 
y 
*r 
I l I 1 1 1 1 1 
100 5 0 2 5 12,5 100 5 0 2 5 12,5 100 5 0 25 12,5 100 5 0 2 5 12,5 100 5 0 25 12,5 
lnhibitor(/xg) 
Fig. 5. Inhibition o f B27-specific cytotoxicity with MS2-polymerase-fusion proteins. The T-cell W M 
( H L A - A 2 , B17, B51, C w l , Cw6) was stimulated with PBL Has ( H L A - A 2 , A3, B27, B37, C w l ) . 21 days 
later cytotoxicity was tested on the target L C L LG2 (A2, B27, C w l ) with an effector:target ratio of 5:1. 
The solid line symbolizes the specific lysis without inhibitor; the concentrations of inhibitor (fusion 
proteins) are given in / ig/200/i l microculture. 
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MS39 that obviously recognizes an unidentified bac-
terial product present in all fusion proteins and MS52 
that is specific for an epitope in the third domain, the 
other monoclonals bind to determinants present on 
the first, second and third domains. Although D l and 
D3 share no common amino acid sequences, similar 
three-dimensional structures may be formed that are 
recognized by the monoclonal antibodies. The 
specificity of the MS-antibodies for class I was shown 
by precipitation of HLA-antigens followed by 
Western blotting and isoelectric focussing. The 
precipitation of H L A - A 2 , -B27 and -Cwl from 
cellular lysates of the HLA-homozygous L C L LG2 
means either that the antibodies recognize a mono-
morphic determinant on class I molecules or that 
complexes of class I antigens in the lysate lead to 
coprecipitation. At least the data show that the 
anti-fusion protein antibodies are specific for H L A -
class I , as demonstrated by comparison with the 
binding patterns of W6/32 and HC10. 
According to Kourilsky and Claverie (1986), 
cytotoxic T-cells should recognize their antigens as 
peptides in the same way as T-helper cells. In these 
studies fusion proteins were used as antigens to 
analyze both T-cell subsets. Using macrophages as 
antigen presenting cells it is expected that antigenic 
peptides could be processed from fusion proteins. 
Stimulation of T-helper cells to secrete IL-2 showed 
that the responding cells recognized fusion protein 
D l / 2 , but not D l or D2 alone. It is likely that one 
antigenic determinant is located in the region around 
amino acid position 114, where D l and D2 are 
dissected. Restimulation with PBL of B27 + and B27" 
donor cells resulted in a significantly higher second-
ary response to B27-positive cells by those PBL 
initially primed to D l / 2 , thus for T-helper cells the 
fusion proteins can obviously function as H L A -
analogues. Cytotoxic T-cells seemed to be stimulated 
by an unknown antigen present in all fractions of 
fusion proteins. Since, however, cytotoxicity was 
greater for B27 + cells it raises an interesting point 
regarding M H C and disease association with respect 
to HLA-B27, since crossreactivity between bacterial 
antigens and M H C antigen has been proposed as one 
mechanism resulting in development of Ankylosing 
Spondylitis in B27 + individuals (Schwimmbeck et al., 
1987; Chen et al., mi). 
The failure to clearly detect HLA-B27 specific 
responses raises a number of questions about the 
applicability of fusion proteins for studying allo-
antigens. A major problem arises with the denatured 
form of the fusion proteins which are precipitated as 
inclusion bodies in bacterial cells. The purification 
procedures enabling one to obtain suitable material 
for cellular assays cannot exclude contamination with 
bacterial proteins which may give rise to non-specific 
immune responses. 
It must also be considered that the bacterial part 
of the fusion protein (ß-galactosidase or 
MS2-polymerase) may interact with the B27 se-
quence, such that important determinants of B27 are 
covered or altered in structure. I t may also be that the 
bacterial partners alter processing so that appropriate 
allopeptides could not be generated. These problems 
will only be solved with new generation vectors that 
enable isolation of recombinant molecules in soluble 
and native form and enable easy removal of the 
bacterial part of the molecule, for example through 
specific protease digestion. 
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